Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
396.61 Down 15.98(3.87%) 4:00PM EST
|After Hours : 397.66 Up 1.05 (0.26%) 7:57PM EST
Prev Close:412.59
Open:416.10
Bid:390.00 x 100
Ask:412.20 x 200
1y Target Est:594.30
Beta:1.80611
Next Earnings Date: 9-Feb-16REGN Earnings announcement
Day's Range:393.07 - 420.53
52wk Range:392.35 - 605.93
Volume:1,432,659
Avg Vol (3m):809,280
Market Cap:42.06B
P/E (ttm):78.33
EPS (ttm):5.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 3.87%42.06B
AMGNDown 3.25%109.36B

Key Statistics

Forward P/E (1 yr):28.23
P/S (ttm):11.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :12.53
Quarterly EPS Est (Dec-15) :3.31
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback